SEC Tracker
Get the app
RXST · XBRL financial data

RxSight financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (RXST's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue——————33,63730,340——33,74124,586
Revenue from contracts with customers28,580*29,51234,88735,31440,214*37,89533,63730,34032,608*30,89327,24124,546
Cost of goods and services sold10,926*8,82710,63710,09411,426*9,5668,4476,1137,345*7,3957,8556,487
Gross profit17,654*20,68524,25025,22028,788*28,32925,19024,22725,263*23,498——
Research and development7,341*8,0318,2918,8389,207*10,36710,2179,0608,905*9,4729,2379,213
Selling, general and administrative21,165*23,32424,29225,60828,209*28,63628,97627,34527,695*31,85530,41927,404
Total operating expenses28,506*31,35532,58334,44637,416*39,00339,19336,40536,600*41,32747,51143,104
Operating income (loss)(10,852)*(10,670)(8,333)(9,226)(8,628)*(10,674)(14,003)(12,178)(11,337)*(17,829)(13,770)(18,518)
Interest expense4*6655*6545*333
Income tax expense (benefit)(18)*9161312*1832105*68828
Net income (loss)(9,177)*(9,100)(6,079)(6,338)(5,938)*(8,190)(11,786)(9,816)(9,152)*(15,884)(12,097)(16,224)
Earnings per share, basic USD per share(0.26)*(0.25)(0.16)(0.16)(0.15)*(0.20)(0.29)(0.24)(0.22)*(0.38)(0.29)(0.39)
Earnings per share, diluted USD per share(0.26)*(0.25)(0.16)(0.16)(0.15)*(0.20)(0.29)(0.24)(0.22)*(0.38)(0.29)(0.39)
Weighted average shares, basic thousands of shares35,962*36,84338,45639,78940,357*40,51040,74440,96541,176*41,30641,49141,705
Weighted average shares, diluted thousands of shares35,962*36,84338,45639,78940,357*40,51040,74440,96541,176*41,30641,49141,705

Balance sheet

CSV

Fiscal quarters (RXST's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents9,69232,64524,44516,72016,70628,00040,35529,63319,94917,57313,35266,717
Short-term investments117,49092,709208,839220,400220,517201,341187,136197,883208,179200,307195,447187,966
Accounts receivable20,28121,55025,72325,36830,05030,95828,05824,15123,38322,44318,51916,998
Inventory17,42118,70019,44321,67322,00923,57425,06128,95031,55934,86937,11739,593
Prepaid and other current assets3,5232,9552,7732,6074,5414,5413,2643,2604,3894,0332,9613,530
Total current assets168,407168,559281,223286,768293,823288,414283,874283,877287,459279,225327,396314,804
Property and equipment, net10,84111,61712,44412,24112,41312,55713,25513,09613,05613,23214,03914,649
Right-of-use asset2,4442,05210,81810,53611,21710,92210,58810,2769,9599,7609,4919,246
Total assets182,550183,165305,499310,469318,563313,044309,009308,533311,814303,993352,700340,418
Accounts payable3,8635,0575,0954,5814,5447,1113,3483,3775,2967,1246,3453,423
Accrued liabilities15,239———20,358———19,795———
Total current liabilities20,90318,32819,61822,63825,87622,74120,38322,29126,25327,37680,44474,952
Lease liability, non-current1,09378810,55310,45611,21610,87910,53410,2009,8139,2658,8678,435
Total liabilities22,18819,23630,29233,20837,32533,72830,99732,56336,13136,69889,36085,507
Accumulated deficit(594,640)(603,740)(609,819)(616,157)(622,095)(630,285)(642,071)(651,887)(661,039)(676,923)(689,020)(705,244)
Total stockholders' equity160,362163,929275,207277,261281,238279,316278,012275,970275,683267,295263,340254,911
Total liabilities and equity182,550183,165305,499310,469318,563313,044309,009308,533311,814303,993352,700340,418
Common shares outstanding (cover page) thousands of shares36,98837,19639,68340,30440,49140,63740,91641,11741,26641,39741,59341,929

Cash flows

CSV

Fiscal quarters (RXST's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(9,177)*(9,100)(6,079)(6,338)(5,938)*(8,190)(11,786)(9,816)(9,152)*(15,884)(12,097)(16,224)
Stock-based compensation4,425*4,6966,105*6,552*7,282*7,1408,547*8,108*7,817*7,9457,465*7,634*
Depreciation and amortization1,051*1,115812*1,133*515*776785*854*851*834999*929*
Net cash from operating activities(8,301)*(9,309)(4,027)*650*(4,260)*(8,832)(4,376)*(1,187)*(1,116)*(10,891)(9,538)*45,216*
Purchases of property and equipment1,591*1,9671,523*1,103*847*5751,537*581*1,137*7591,956*1,174*
Net cash from investing activities4,566*24,274(115,645)*(9,260)*1,320*20,85514,652*(9,004)*(9,614)*8,8484,652*7,946*
Proceeds from issuing common stock3,583*10,1533,840*3,835*2,988*6962,068*131*1,056*144669*227*
Net cash from financing activities3,562*7,992111,473*878*2,976*(735)2,065*(530)*1,063*(336)662*195*
Net change in cash(166)*22,954(8,200)*(7,725)*24*11,29412,355*(10,723)*(9,683)*(2,376)(4,221)*53,365*

Compare with peers

SIC 3851 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3851 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingQuarter
RxSight66,71724,54645,216*41.9M 10-QSep 30, 2026
Bausch & Lomb513,0001,375,000233,000*357.5M 10-QSep 30, 2026
Staar Surgical148,57993,53519,690*50.1M 10-QJul 3, 2026
National Vision Holdings35,998498,8058,110*79.1M 10-QJul 4, 2026
Warby Parker292,674235,51129,618*not reported 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.